Partner Cybil Roehrenbeck honored with Judicial Advocacy Initiative Award from American Cancer Society Cancer Action Network

This prestigious award was presented during a breakfast event on 18 September in Washington, D.C., hosted by ACS CAN President Lisa Lacasse before over 700 cancer patients and survivors from across the U.S. The award honors attorneys who demonstrate exceptional commitment to cancer advocacy through pro bono service and impactful leadership.

Roehrenbeck, a member of the firm’s Government Relations and Public Affairs practice, has dedicated over seven years to this cause, utilizing her extensive advocacy expertise to assist ACS CAN and its partners in the Patient Quality of Life Coalition (PQLC), which aims to improve access to palliative care for individuals with serious illnesses.

Since 2017, Cybil has skillfully led a coalition of over 40 member organizations in formulating responses to Medicare payment proposals, ensuring vital services like telehealth and patient navigation remain accessible to those in need.

ACS CAN is the nation's leading cancer advocacy organization that works tirelessly to make cancer issues a national priority. ACS CAN empowers advocates nationwide to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN is critical to the fight for a world without cancer.

More information on the American Cancer Society Cancer Action Network can be found here.